Why is human diploid cell vaccine preferred over Vero cell vaccines?

Question

Accepted Answer

Human Diploid Cell Vaccines Offer Natural Safety Advantages and Higher Value Compared to Vero Cell Vaccines

Human diploid cell rabies vaccines are generally preferred over Vero cell rabies vaccines due to their inherent safety advantages stemming from their biological origin and their higher market value. These vaccines utilize human diploid cells, which are homologous to human cells, thereby offering a natural safety benefit. While specific details of this advantage are not extensively elaborated, this biological compatibility is a key differentiator.
Homologous Origin Contributes to Safety

The fundamental reason for the preference lies in the use of human diploid cells in their production. Unlike Vero cells, which are of monkey origin, human diploid cells share a natural similarity with human cells. This homology is understood to contribute to a natural safety advantage, although the precise clinical implications or documented differences in safety profiles are not detailed in the provided information.
Higher Cost Reflects Greater Value

A significant factor influencing the market perception and adoption of human diploid cell rabies vaccines is their cost. These vaccines are priced substantially higher, typically three to five times more expensive than Vero cell rabies vaccines. This higher price point is indicative of a greater product added value, suggesting advanced manufacturing processes or superior efficacy that justifies the increased expense for consumers and healthcare providers.
Market Dynamics Favor Higher-Value Products

The rabies vaccine market, particularly in China, is substantial and projected for continued growth, reaching an estimated RMB22.0 billion by 2030. This expansion is partly driven by product upgrades and evolving market demands, such as the growth in the pet market and increased awareness of pre-exposure rabies immunisation. In such a dynamic environment, products with higher added value, like human diploid cell vaccines, are positioned to benefit from these market trends.

Reading history

Hide →

This history is cleared when the page is closed.

Why is human diploid cell vaccine preferred over Vero cell vaccines?

Loading

Was this article helpful?

Helpful

Not helpful

Report an issue

1

0

0

Share with friends